SynthesisBMC cancer2023

Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: a systematic review and meta-analysis.

Xiu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.